Bio-Rad Laboratories Inc (BIO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
- Business description - A detailed description of the company’s operations and business divisions.
- Corporate strategy - Analyst’s summarization of the company’s business strategy.
- SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history - Progression of key events associated with the company.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Executive biographies - A brief summary of the executives’ employment history.
- Key operational heads - A list of personnel heading key departments/functions.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights
Bio-Rad Laboratories Inc (Bio-Rad) develops, manufactures and markets a range of products and systems for life science research, healthcare, analytical chemistry and other markets. The company’s major products include reagents, apparatus, laboratory instruments, test systems, informatics systems, test kits and specialized quality controls. Bio-Rad offers its products to universities and medical schools, industrial research organizations, pharmaceutical manufacturers, government agencies, biotechnology researchers, food producers, food testing laboratories, reference laboratories, hospital and transfusion laboratories and physician office laboratories. It markets products through direct sales force and a network of distributors, agents, brokers and resellers worldwide. The company operates in the US, Canada, Latin America, Europe and Asia, among others. Bio-Rad is headquartered in Hercules, California, the US.Bio-Rad Laboratories Inc Key Recent Developments
- Oct 26, 2023: Bio-Rad Reports Third-Quarter 2023 Financial Results
- Oct 05, 2023: Bio-Rad Extends Range of Anti-Idiotypic Antibodies for Use in Preclinical and Clinical Drug Development
- Sep 28, 2023: Bio-Rad Launches PTC Tempo 48/48 and PTC Tempo 384 Thermal Cyclers
- Aug 29, 2023: Bio-Rad Launches First StarBright Red Dye and Extends Range of Antibody Markers Conjugated to StarBright Dyes to Enhance Multiplex Flow Cytometry and Research Capabilities
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Table of Contents
Section 1 - About the Company
Section 2 - Company Analysis
Section 3 - Company Financial Ratios
Section 4 - Company’s Lifesciences Financial Deals and Alliances
Section 5 - Company’s Recent Developments
Section 6 - Appendix
List of Tables
List of Figures
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Thermo Fisher Scientific Inc
- Danaher Corp
- Siemens Healthineers AG
- Becton Dickinson and Co
- Ortho Clinical Diagnostics Holdings Plc
- Immucor Inc
- bioMerieux SA
- Tosoh Corp
- F. Hoffmann-La Roche Ltd
- Abbott Laboratories
- Becton Dickinson and Co
- Merck Millipore Corp
- bioMerieux SA
- Danaher Corp
- Siemens Healthineers AG
- Diasorin SA
- Tosoh Corp
- F. Hoffmann-La Roche Ltd
- Thermo Fisher Scientific Inc
- Abbott Laboratories
- GE Biosciences
- Ortho Clinical Diagnostics Holdings Plc
- Immucor Inc